Using the SURA electrodevice to improve gait in stroke survivors
Effects of Proprioceptive Sensitivity Stimulation Via the SURA Electrodevice on Kinematics, Kinetics and Spatiotemporal Parameters of Gait: a Pilot Study.
NA · Facultat de ciencies de la Salut Universitat Ramon Llull · NCT06395272
This study is testing whether a special device can help stroke survivors improve their walking and balance better than regular rehab alone.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Facultat de ciencies de la Salut Universitat Ramon Llull (other) |
| Locations | 1 site (Barcelona, Vilafranca Del Penedés) |
| Trial ID | NCT06395272 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the SURA electrodevice in enhancing dynamic balance and gait parameters in individuals who have experienced a stroke. Participants will be randomly assigned to either an intervention group, receiving proprioceptive stimulation via the device, or a control group, undergoing similar rehabilitation without the device. The intervention involves targeted stimulation of specific muscle motor points to optimize sensorimotor circuit engagement. The study aims to assess improvements in kinematics, kinetics, and spatiotemporal gait parameters over the course of treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 85 who have experienced a unilateral hemispheric stroke and can walk at least 10 meters with some assistance.
Not a fit: Patients with cognitive, visual, or cardiorespiratory disorders, or those who have undergone recent orthopedic interventions, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance gait recovery and overall mobility in stroke survivors.
How similar studies have performed: While the use of proprioceptive stimulation in rehabilitation is established, the specific application of the SURA electrodevice represents a novel approach that has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Unilateral hemispheric stroke (ischaemic or haemorrhagic) diagnosed by MRI or CT scan, at least 3 months after onset of stroke * Ability to walk at least 10m (irrespective of the need for assistance) * Weakness in ankle dorsiflexion of the paretic limb (TFM\>3) * Ankle ROM \>30° and 0° of foot dorsiflexion in knee extension * Age between 18 and 85 years * Mini-Mental State Examination (MMSE) \> 24 score, non-disabling cognitive impairment * Presence of clonus and hyperresistance to passive joint movement. Exclusion Criteria: * Diagnosis of Cognitive, visual or cardiorespiratory disorder (including cardiac pacemaker placement, heart failure and arrhythmia) * Orthopaedic intervention for IE * Balance disorders with vestibular features * Skin diseases * Botulinum toxin treatment within the last year. * In addition, subjects who had participated in other studies in the last six months that could interact with the current study will be excluded.
Where this trial is running
Barcelona, Vilafranca Del Penedés
- CSSV-Rif — Barcelona, Vilafranca Del Penedés, Spain (RECRUITING)
Study contacts
- Study coordinator: Pedro Victor López Plaza
- Email: pedrovictorlp@blanquerna.url.edu
- Phone: 932 53 32 56
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke